Title: 1 1. Strike the original sections and insert the following new
Official Title: 1 1. Strike the original sections and insert the following new
Number of Sections: 1
Source: versions - Banking, Commerce and Insurance AM1201 Jacobson AM1229
Media Type: application/pdf
Strikethrough Detection: 11 sections found

================================================================================

Section 1:
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
AMENDMENTS TO LB198
Introduced by Banking, Commerce and Insurance.
2 sections:
3 Section 1. Section 44-4601, Revised Statutes Cumulative Supplement,
4 2024, is amended to read:
5 44-4601 Sections 44-4601 to 44-4612 and sections 4 to 8 of this act
6 shall be known and may be cited as the Pharmacy Benefit Manager Licensure
7 and Regulation Act.
8 Sec. 2. Section 44-4603, Revised Statutes Cumulative Supplement,
9 2024, is amended to read:
10 44-4603 For purposes of the Pharmacy Benefit Manager Licensure and
11 Regulation Act:
12 (1) Auditing entity means a pharmacy benefit manager or any person
13 that represents a pharmacy benefit manager in conducting an audit for
14 compliance with a contract between the pharmacy benefit manager and a
15 pharmacy;
16 (2) Claims processing service means an administrative service
17 performed in connection with the processing and adjudicating of a claim
18 relating to a pharmacist service that includes:
19 (a) Receiving a payment for a pharmacist service; or
20 (b) Making a payment to a pharmacist or pharmacy for a pharmacist
21 service;
22 (3) Clinician-administered drug means an outpatient prescription
23 drug other than a vaccine that:
24 (a) Cannot reasonably be self-administered by the covered person to
25 whom the drug is prescribed or by an individual assisting the covered
26 person with self-administration; and
27 (b) Is typically administered:
-1-
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 (i) By a health care provider authorized to administer the drug,
2 including when acting under a physician's delegation and supervision; and
3 (ii) In a physician's office, hospital outpatient infusion center,
4 or other clinical setting;
5 (4) (3) Covered person means a member, policyholder, subscriber,
6 enrollee, beneficiary, dependent, or other individual participating in a
7 health benefit plan;
8 (5) (4) Director means the Director of Insurance;
9 (6) (5) Health benefit plan means a policy, contract, certificate,
10 plan, or agreement entered into, offered, or issued by a health carrier
11 or self-funded employee benefit plan to the extent not preempted by
12 federal law to provide, deliver, arrange for, pay for, or reimburse any
13 of the costs of a physical, mental, or behavioral health care service;
14 (7) (6) Health carrier has the same meaning as in section 44-1303;
15 (8) Maintenance medication means a drug prescribed for a chronic,
16 long-term condition and taken on a regular, recurring basis;
17 (9) Network pharmacist means a pharmacist that has a contract,
18 either directly or through a pharmacy services administrative
19 organization, with a pharmacy benefit manager to provide covered drugs at
20 a negotiated reimbursement rate;
21 (10) Network pharmacy means a pharmacy that has a contract, either
22 directly or through a pharmacy services administrative organization, with
23 a pharmacy benefit manager to provide covered drugs at a negotiated
24 reimbursement rate;
25 (11) (7) Other prescription drug or device service means a service
26 other than a claims processing service, provided directly or indirectly,
27 whether in connection with or separate from a claims processing service,
28 including, but not limited to:
29 (a) Negotiating a rebate, discount, or other financial incentive or
30 arrangement with a drug company;
31 (b) Disbursing or distributing a rebate;
-2-
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 (c) Managing or participating in an incentive program or arrangement
2 for a pharmacist service;
3 (d) Negotiating or entering into a contractual arrangement with a
4 pharmacist or pharmacy;
5 (e) Developing and maintaining a formulary;
6 (f) Designing a prescription benefit program; or
7 (g) Advertising or promoting a service;
8 (12) Participating provider has the same meaning as in section
9 44-7103;
10 (13) (8) Pharmacist has the same meaning as in section 38-2832;
11 (14) (9) Pharmacist service means a product, good, or service or any
12 combination thereof provided as a part of the practice of pharmacy;
13 (15) (10) Pharmacy has the same meaning as in section 71-425;
14 (16)(a) (11)(a) Pharmacy benefit manager means a person, business,
15 or entity, including a wholly or partially owned or controlled subsidiary
16 of a pharmacy benefit manager, that provides a claims processing service
17 or other prescription drug or device service for a health benefit plan to
18 a covered person who is a resident of this state; and
19 (b) Pharmacy benefit manager does not include:
20 (i) A health care facility licensed in this state;
21 (ii) A health care professional licensed in this state;
22 (iii) A consultant who only provides advice as to the selection or
23 performance of a pharmacy benefit manager; or
24 (iv) A health carrier to the extent that it performs any claims
25 processing service or other prescription drug or device service
26 exclusively for its enrollees; and
27 (17) Pharmacy benefit manager affiliate means a pharmacy or
28 pharmacist that directly or indirectly, through one or more
29 intermediaries, owns or controls, is owned or controlled by, or is under
30 common ownership or control with a pharmacy benefit manager;
31 (18) Pharmacy services administrative organization means an entity
-3-
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 that provides a contracted pharmacy with contracting administrative
2 services relating to prescription drug benefits;
3 (19) (12) Plan sponsor has the same meaning as in section 44-2702; .
4 (20) Specialty pharmacy means a pharmacy that specializes in
5 dispensing drugs for patients with rare or complex medical conditions or
6 in prescription drugs that have specific storage or dispensing
7 requirements; and
8 (21) Spread pricing means the method of pricing a drug in which the
9 contracted price for a drug that a pharmacy benefit manager charges a
10 health benefit plan differs from the amount the pharmacy benefit manager
11 directly or indirectly pays the pharmacist or pharmacy for pharmacist
12 services.
13 Sec. 3. Section 44-4610, Revised Statutes Cumulative Supplement,
14 2024, is amended to read:
15 44-4610 (1) A pharmacy benefit manager shall not exclude a Nebraska
16 pharmacy from participation in the pharmacy benefit manager's specialty
17 pharmacy network if:
18 (a) (1) The pharmacy holds a specialty pharmacy accreditation from a
19 nationally recognized independent accrediting organization; and
20 (b) (2) The pharmacy is willing to accept the terms and conditions
21 of the pharmacy benefit manager's agreement with the pharmacy benefit
22 manager's specialty pharmacies.
23 (2) A pharmacy benefit manager shall not:
24 (a) Apply terms and conditions to an unaffiliated specialty pharmacy
25 that are stricter than the terms and conditions required for any
26 specialty pharmacy affiliated with the pharmacy benefit manager;
27 (b) Apply terms and conditions to specialty pharmacies that are
28 inconsistent with the Pharmacy Benefit Manager Licensure and Regulation
29 Act; or
30 (c) Require data reporting from specialty pharmacies more frequently
31 than quarterly unless reasonably necessary for the pharmacy benefit
-4-
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 manager to collect or report data obtained pursuant to subdivision (3)(a)
2 or (b) of this section.
3 (3) A pharmacy benefit manager shall not impose reporting terms and
4 conditions that require a specialty pharmacy to collect and remit data
5 unless such terms and conditions are:
6 (a) Necessary for a pharmacy benefit manager to meet reporting
7 obligations required by federal or state laws or regulations;
8 (b) Related to data (i) that may only be obtained from the specialty
9 pharmacy and (ii) that a pharmacy benefit manager is contractually
10 obligated to provide to another entity in order for that entity to meet
11 reporting obligations required by federal or state laws or regulations;
12 (c) Necessary for purposes of payment integrity or rebate
13 administration; or
14 (d) Submitted by the specialty pharmacy to the nationally recognized
15 independent accrediting organization from which the specialty pharmacy
16 holds an accreditation.
17 (4) In addition to other terms and conditions consistent with this
18 section, a pharmacy benefit manager may impose contract terms and
19 conditions that are reasonably necessary to demonstrate that the
20 specialty pharmacy has sufficient:
21 (a) Policies and metrics related to providing quality and consistent
22 care for patients using the pharmacy; and
23 (b) Policies and procedures consistent with industry standards to
24 avoid instances of fraud, waste, or abuse.
25 Sec. 4. (1) A specialty pharmacy that ships a clinician-
26 administered drug to a health care provider or pharmacy shall:
27 (a) Comply with all federal laws regulating the shipment of drugs,
28 including, but not limited to, general chapter 800 of the United States
29 Pharmacopeia;
30 (b) In response to questions from a health care provider or
31 pharmacy, provide access to a pharmacist or nurse employed by the
-5-
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 specialty pharmacy twenty-four hours per day, seven days per week;
2 (c) Allow a covered person and health care provider to request a
3 refill of a clinician-administered drug on behalf of a covered person in
4 accordance with the pharmacy benefit manager's or health carrier's
5 utilization review procedures; and
6 (d) Adhere to the track and trace requirements, as described in the
7 federal Drug Supply Chain Security Act, 21 U.S.C. 360eee et seq., for a
8 clinician-administered drug that needs to be compounded or manipulated
9 and, if requested by the health care provider or the provider's designee,
10 provide the track and trace information to the health care provider or
11 designee.
12 (2) For any clinician-administered drug dispensed by a specialty
13 pharmacy selected by the pharmacy benefit manager or health carrier, the
14 requesting health care provider or the provider's designee shall provide
15 the requested date, approximate time, and place of delivery of a
16 clinician-administered drug at least five business days before the date
17 of delivery. The specialty pharmacy shall require a signature of the
18 health care provider or the provider's designee upon receipt of the
19 shipment when shipped to a health care provider. If any clinician-
20 administered drug dispensed by a specialty pharmacy is not delivered as
21 specified in this subsection, the covered person shall not be financially
22 responsible if the clinician-administered drug is not able to be
23 administered to the covered person.
24 (3) The requirements of subsections (1) and (2) of this section do
25 not apply when the specialty pharmacy and the health care provider
26 administering the clinician-administered drug have shared ownership.
27 (4) A pharmacy benefit manager or health carrier that requires
28 dispensing of a clinician-administered drug through a specialty pharmacy
29 shall establish and disclose a process which allows the health care
30 provider or pharmacy to appeal and have exceptions to the use of a
31 specialty pharmacy when:
-6-
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 (a) A drug is not delivered as specified in subsection (2) of this
2 section; or
3 (b) An attending health care provider reasonably believes a covered
4 person may experience harm without the immediate use of a clinician-
5 administered drug that a health care provider or pharmacy has in stock.
6 (5) A pharmacy benefit manager or health carrier shall not:
7 (a) Require a specialty pharmacy to dispense a covered clinician-
8 administered drug directly to a covered person with the intention that
9 the covered person will transport the clinician-administered drug to a
10 health care provider for administration;
11 (b) Refuse to authorize or reimburse a participating provider for
12 dispensing a covered clinician-administered drug based on costs if the
13 costs of the drug to the health benefit plan are substantially similar as
14 compared to the costs of the drug if provided from a specialty pharmacy
15 selected by the pharmacy benefit manager or health carrier;
16 (c) Refuse to authorize or reimburse a participating provider
17 pursuant to the network agreement for the administration of covered
18 clinician-administered drugs;
19 (d) Penalize or remove from the network a participating provider
20 solely for refusing to administer a covered clinician-administered drug
21 received from a specialty pharmacy selected by the pharmacy benefit
22 manager or health carrier. If a participating provider refuses to source
23 covered clinician-administered drugs from a specialty pharmacy selected
24 by the pharmacy benefit manager or health carrier, the participating
25 provider shall direct the covered person to contact the health carrier
26 for coverage options; or
27 (e) Require a covered person to obtain a clinician-administered drug
28 from a specialty pharmacy selected by the pharmacy benefit manager or
29 health carrier if a participating provider of the covered person's choice
30 sources the drug at a substantially similar cost and provides for
31 administration at a substantially similar cost.
-7-
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 Sec. 5. (1) A health benefit plan, health carrier, or pharmacy
2 benefit manager shall not:
3 (a) Require a covered person, as a condition of payment or
4 reimbursement, to obtain pharmacist services exclusively through the
5 mail-order pharmacy or pharmacy benefit manager affiliate;
6 (b) Prohibit or limit a covered person from selecting a network
7 pharmacist or network pharmacy of the covered person's choice;
8 (c) Transfer a covered person's prescriptions from a network
9 pharmacy to another pharmacy unless requested by the covered person;
10 (d) Use financial incentives, including, but not limited to,
11 adjustments in cost-sharing obligations of a covered person, to the
12 exclusive benefit of the pharmacy benefit manager affiliate pharmacy; or
13 (e) Except as provided in subdivision (2)(b) of this section, auto-
14 enroll a covered person in mail-order pharmacist services.
15 (2) Nothing in this section shall be construed to prevent a health
16 benefit plan, health carrier, or pharmacy benefit manager from:
17 (a) Requiring a covered person to use a network specialty pharmacy;
18 (b) Auto-enrolling a covered person in mail-order pharmacist
19 services for a maintenance medication, provided that a covered person:
20 (i) Shall not be auto-enrolled for the first ninety days of a new
21 maintenance medication; and
22 (ii) Shall have the ability to opt out of mail-order pharmacist
23 services at any time;
24 (c) Informing a covered person of an ability to obtain pharmacist
25 services at a lower cost; or
26 (d) Requiring a covered person to obtain pharmacist services from a
27 mail-order pharmacy or pharmacy benefit manager affiliate when such
28 services are not otherwise available from another network pharmacy.
29 Sec. 6. (1) A network pharmacy or network pharmacist may decline to
30 provide a drug if the pharmacy or pharmacist will be or is paid less than
31 the acquisition cost for the drug.
-8-
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 (2) If a network pharmacy or network pharmacist declines to provide
2 a drug as authorized in subsection (1) of this section, the pharmacy or
3 pharmacist shall provide the covered person with adequate information as
4 to where the prescription for the drug may be filled or shall refer the
5 covered person to his or her plan sponsor.
6 (3) A pharmacy benefit manager, pharmacy services administrative
7 organization, or any person acting on behalf of a pharmacy benefit
8 manager or pharmacy services administrative organization shall not
9 penalize, remove from the network, or otherwise retaliate against a
10 network pharmacy or network pharmacist solely for declining to provide a
11 drug as provided in subsection (1) of this section.
12 Sec. 7. (1) A contract between a retail pharmacy and a pharmacy
13 benefit manager or plan sponsor shall not prohibit the retail pharmacy
14 from offering the following as an ancillary service of the retail
15 pharmacy:
16 (a) The delivery of a prescription drug by mail or common carrier to
17 a covered person or his or her personal representative on request of the
18 covered person or personal representative if the request is made before
19 the drug is delivered; or
20 (b) The delivery of a prescription to a covered person or his or her
21 personal representative by an employee or contractor of the retail
22 pharmacy.
23 (2) Nothing in this section shall require a retail pharmacy to
24 receive a request from a covered person or his or her personal
25 representative for delivery of a drug by mail, common carrier, or an
26 employee or contractor of the retail pharmacy when refilling or renewing
27 prescription drug services for which a request was previously received,
28 so long as the retail pharmacy has confirmed that the covered person
29 wishes to receive the drug.
30 (3) A pharmacy benefit manager or plan sponsor shall not remove a
31 retail pharmacy from its networks or require a retail pharmacy to join a
-9-
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 mail-order pharmacy network for the sole reason of providing ancillary
2 delivery services as long as the ancillary delivery services were
3 provided in compliance with this section and with the terms and
4 conditions of the retail pharmacy's contract with the pharmacy benefit
5 manager or plan sponsor and its pharmacy services administrative
6 organization, if applicable.
7 (4) Except as otherwise provided in a contract described in
8 subsection (1) of this section, a retail pharmacy shall not charge a plan
9 sponsor or pharmacy benefit manager for the delivery service described in
10 subsection (1) of this section.
11 (5) If a retail pharmacy provides a delivery service described in
12 subsection (1) of this section to a covered person, the retail pharmacy
13 shall disclose both of the following to the covered person or his or her
14 personal representative:
15 (a) Any fee charged to the covered person for the delivery of a
16 prescription drug; and
17 (b) That the plan sponsor or pharmacy benefit manager may not
18 reimburse the covered person for the fee described in subdivision (a) of
19 this subsection.
20 (6) For purposes of this section, retail pharmacy means a pharmacy
21 that dispenses prescription drugs to the public at retail primarily to
22 individuals who reside in close proximity or who are receiving care from
23 a provider in close proximity to the pharmacy, typically by face-to-face
24 interaction with the individual or the individual's caregiver.
25 Sec. 8. (1) A contract between a pharmacy benefit manager and a
26 health benefit plan that is issued on or after January 1, 2026, shall not
27 contain spread pricing unless such contract is an extension of a contract
28 entered into prior to January 1, 2026, which included spread pricing.
29 (2) Beginning January 1, 2029, no contract between a pharmacy
30 benefit manager and a health benefit plan shall include spread pricing.
31 Sec. 9. This act becomes operative on January 1, 2026.
-10-
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 Sec. 10. Original sections 44-4601, 44-4603, and 44-4610, Revised
2 Statutes Cumulative Supplement, 2024, are repealed.
-11-
[DELETED: yB1 S t o s a i t f nsS24saS 2 S 4 R S C S2041R2(3t r a p b m i c a a f4c w a c b t p b m a 5p6( C p s m a a s7p8r9(0(1s2( C d m a o p3d4(5w t d i p o b a i a t c6p7(1A8L5M]
[DELETED: ( B a h c p a t a t di(o( ( C p m a m p seh((0p1o s e b p t t e n p b2f3o4(5( M m m a d p f a c6l7( N p m a p t h a c8e d o t a p s a9o0a1(2d3a p b m t p c d a a n4r5(6o7w8i9(0a1(1A8L5M]
[DELETED: (f( N o e i a c a w p(((( P p h t s m a i s40(1(2c3(4(5o6o7o8a9(0(1(2(3p4( A h c t t e t i p a c5p s o o p d o d s6e7( P b m a m a p o8p t d o i t o o m9i0c1( P s a o m a e1A8L5M]
[DELETED: t p a c p w c as(( S p m a p t s idi p d t h s s o dr(c p f a d t a p b m c 0h1d o i p t p o p f p2s3S 3 S 4 R S C S42546p7p8(9n0(1o t p b m a w t p b2m3(4(5t a s t t t a c r f a6s7( A t a c t s p t a8i9A0(1t q u r n f t p b1A8L5M]
[DELETED: mo(cu( N f a p b m t m ro(p a ( t a p b m i c0o1r2( N f p o p i o r3a4(5i a o f w t s p6h7(8s a p b m m i c t a9c t a r n t d t t0s1(2c3( P a p c w i s t4a5S 4  ( A s p t s a c6a7(8i9P0( I r t q f a h c p o1p p a t a p o n e b t1A8L5M]
[DELETED: s( A a c p a h c p t r ra w t p b m o h cu(fc d t n t b c o ma0p1d2( F a c d d b a s3p4r5t r d a t a p o d o 6c7o d T s p s r a s o t8h c p o t p d u r o t9s w s t a h c p I a c0a1s2r i t c d i n a t b3a4(5n a w t s p a t h c p6a7( A p b m o h c t r8d9s e a d a p w a t h c0p o p t a a h e t t u o 1s1A8L5M]
[DELETED: (s(p m e h w t i u o a ca(( R a s p t d a c cat c p w t t c d t 0h1( R t a o r a p p f2d a c c d b o c i t3c4c5s6( R t a o r a p p7p t t n a f t a o c8c9( P o r f t n a p p0s1r f a s p s b t p b2m3c4b t p b m o h c t p5p6f7(8f a s p s b t p b m o9h0s t d a a s s c a p f1a1A8L5M]
[DELETED: S 5  ( A h b p h c o pb( R a c p a a c o p or t o p s e t tm( P o l a c p f s a np( T a c p p f a np0( U f i i b n l t1a i c o o a c p t t2e3(4e5(6b7(8( A a c p i m p9s0(1m2( S h t a t o o o m p3s4( I a c p o a a t o p5s6(7m p o p b m a w s8s9S0p1t1A8L5M]
[DELETED: (aptc( A p b m p s ao o a p a o b o a p bm o p s a o s np r f t n o o r a 0n1d2S 7  ( A c b a r p a a p3b4f o t f a a a s o t r5p6(7a8c9t0(1p r b a e o c o t r2p3( N i t s s r a r p t4r a r f a c p o h o h p5r f d o a d b m c c o a6e7p8s l a t r p h c t t c p9w0(1r1A8L5M]
[DELETED: m p n f t s r o p ad s a l a t a d s wp i c w t s a w t t ac o t r p c w t p bm o p s a i p s ao( E a o p i a c d iss0s1( I a r p p a d s d i2s3s4p5( A f c t t c p f t d o 6p7( T t p s o p b m m n8r9t0(1t2i3a4i5S 8  ( A c b a p b m a 6h7c8e9( B J 1 2 n c b a p0b1S1A8L5M]
[DELETED: SS1A8L5M]


================================================================================

Raw Text:
AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
AMENDMENTS TO LB198
Introduced by Banking, Commerce and Insurance.
1 1. Strike the original sections and insert the following new
2 sections:
3 Section 1. Section 44-4601, Revised Statutes Cumulative Supplement,
4 2024, is amended to read:
5 44-4601 Sections 44-4601 to 44-4612 and sections 4 to 8 of this act
6 shall be known and may be cited as the Pharmacy Benefit Manager Licensure
7 and Regulation Act.
8 Sec. 2. Section 44-4603, Revised Statutes Cumulative Supplement,
9 2024, is amended to read:
10 44-4603 For purposes of the Pharmacy Benefit Manager Licensure and
11 Regulation Act:
12 (1) Auditing entity means a pharmacy benefit manager or any person
13 that represents a pharmacy benefit manager in conducting an audit for
14 compliance with a contract between the pharmacy benefit manager and a
15 pharmacy;
16 (2) Claims processing service means an administrative service
17 performed in connection with the processing and adjudicating of a claim
18 relating to a pharmacist service that includes:
19 (a) Receiving a payment for a pharmacist service; or
20 (b) Making a payment to a pharmacist or pharmacy for a pharmacist
21 service;
22 (3) Clinician-administered drug means an outpatient prescription
23 drug other than a vaccine that:
24 (a) Cannot reasonably be self-administered by the covered person to
25 whom the drug is prescribed or by an individual assisting the covered
26 person with self-administration; and
27 (b) Is typically administered:
-1-

AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 (i) By a health care provider authorized to administer the drug,
2 including when acting under a physician's delegation and supervision; and
3 (ii) In a physician's office, hospital outpatient infusion center,
4 or other clinical setting;
5 (4) (3) Covered person means a member, policyholder, subscriber,
6 enrollee, beneficiary, dependent, or other individual participating in a
7 health benefit plan;
8 (5) (4) Director means the Director of Insurance;
9 (6) (5) Health benefit plan means a policy, contract, certificate,
10 plan, or agreement entered into, offered, or issued by a health carrier
11 or self-funded employee benefit plan to the extent not preempted by
12 federal law to provide, deliver, arrange for, pay for, or reimburse any
13 of the costs of a physical, mental, or behavioral health care service;
14 (7) (6) Health carrier has the same meaning as in section 44-1303;
15 (8) Maintenance medication means a drug prescribed for a chronic,
16 long-term condition and taken on a regular, recurring basis;
17 (9) Network pharmacist means a pharmacist that has a contract,
18 either directly or through a pharmacy services administrative
19 organization, with a pharmacy benefit manager to provide covered drugs at
20 a negotiated reimbursement rate;
21 (10) Network pharmacy means a pharmacy that has a contract, either
22 directly or through a pharmacy services administrative organization, with
23 a pharmacy benefit manager to provide covered drugs at a negotiated
24 reimbursement rate;
25 (11) (7) Other prescription drug or device service means a service
26 other than a claims processing service, provided directly or indirectly,
27 whether in connection with or separate from a claims processing service,
28 including, but not limited to:
29 (a) Negotiating a rebate, discount, or other financial incentive or
30 arrangement with a drug company;
31 (b) Disbursing or distributing a rebate;
-2-

AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 (c) Managing or participating in an incentive program or arrangement
2 for a pharmacist service;
3 (d) Negotiating or entering into a contractual arrangement with a
4 pharmacist or pharmacy;
5 (e) Developing and maintaining a formulary;
6 (f) Designing a prescription benefit program; or
7 (g) Advertising or promoting a service;
8 (12) Participating provider has the same meaning as in section
9 44-7103;
10 (13) (8) Pharmacist has the same meaning as in section 38-2832;
11 (14) (9) Pharmacist service means a product, good, or service or any
12 combination thereof provided as a part of the practice of pharmacy;
13 (15) (10) Pharmacy has the same meaning as in section 71-425;
14 (16)(a) (11)(a) Pharmacy benefit manager means a person, business,
15 or entity, including a wholly or partially owned or controlled subsidiary
16 of a pharmacy benefit manager, that provides a claims processing service
17 or other prescription drug or device service for a health benefit plan to
18 a covered person who is a resident of this state; and
19 (b) Pharmacy benefit manager does not include:
20 (i) A health care facility licensed in this state;
21 (ii) A health care professional licensed in this state;
22 (iii) A consultant who only provides advice as to the selection or
23 performance of a pharmacy benefit manager; or
24 (iv) A health carrier to the extent that it performs any claims
25 processing service or other prescription drug or device service
26 exclusively for its enrollees; and
27 (17) Pharmacy benefit manager affiliate means a pharmacy or
28 pharmacist that directly or indirectly, through one or more
29 intermediaries, owns or controls, is owned or controlled by, or is under
30 common ownership or control with a pharmacy benefit manager;
31 (18) Pharmacy services administrative organization means an entity
-3-

AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 that provides a contracted pharmacy with contracting administrative
2 services relating to prescription drug benefits;
3 (19) (12) Plan sponsor has the same meaning as in section 44-2702; .
4 (20) Specialty pharmacy means a pharmacy that specializes in
5 dispensing drugs for patients with rare or complex medical conditions or
6 in prescription drugs that have specific storage or dispensing
7 requirements; and
8 (21) Spread pricing means the method of pricing a drug in which the
9 contracted price for a drug that a pharmacy benefit manager charges a
10 health benefit plan differs from the amount the pharmacy benefit manager
11 directly or indirectly pays the pharmacist or pharmacy for pharmacist
12 services.
13 Sec. 3. Section 44-4610, Revised Statutes Cumulative Supplement,
14 2024, is amended to read:
15 44-4610 (1) A pharmacy benefit manager shall not exclude a Nebraska
16 pharmacy from participation in the pharmacy benefit manager's specialty
17 pharmacy network if:
18 (a) (1) The pharmacy holds a specialty pharmacy accreditation from a
19 nationally recognized independent accrediting organization; and
20 (b) (2) The pharmacy is willing to accept the terms and conditions
21 of the pharmacy benefit manager's agreement with the pharmacy benefit
22 manager's specialty pharmacies.
23 (2) A pharmacy benefit manager shall not:
24 (a) Apply terms and conditions to an unaffiliated specialty pharmacy
25 that are stricter than the terms and conditions required for any
26 specialty pharmacy affiliated with the pharmacy benefit manager;
27 (b) Apply terms and conditions to specialty pharmacies that are
28 inconsistent with the Pharmacy Benefit Manager Licensure and Regulation
29 Act; or
30 (c) Require data reporting from specialty pharmacies more frequently
31 than quarterly unless reasonably necessary for the pharmacy benefit
-4-

AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 manager to collect or report data obtained pursuant to subdivision (3)(a)
2 or (b) of this section.
3 (3) A pharmacy benefit manager shall not impose reporting terms and
4 conditions that require a specialty pharmacy to collect and remit data
5 unless such terms and conditions are:
6 (a) Necessary for a pharmacy benefit manager to meet reporting
7 obligations required by federal or state laws or regulations;
8 (b) Related to data (i) that may only be obtained from the specialty
9 pharmacy and (ii) that a pharmacy benefit manager is contractually
10 obligated to provide to another entity in order for that entity to meet
11 reporting obligations required by federal or state laws or regulations;
12 (c) Necessary for purposes of payment integrity or rebate
13 administration; or
14 (d) Submitted by the specialty pharmacy to the nationally recognized
15 independent accrediting organization from which the specialty pharmacy
16 holds an accreditation.
17 (4) In addition to other terms and conditions consistent with this
18 section, a pharmacy benefit manager may impose contract terms and
19 conditions that are reasonably necessary to demonstrate that the
20 specialty pharmacy has sufficient:
21 (a) Policies and metrics related to providing quality and consistent
22 care for patients using the pharmacy; and
23 (b) Policies and procedures consistent with industry standards to
24 avoid instances of fraud, waste, or abuse.
25 Sec. 4. (1) A specialty pharmacy that ships a clinician-
26 administered drug to a health care provider or pharmacy shall:
27 (a) Comply with all federal laws regulating the shipment of drugs,
28 including, but not limited to, general chapter 800 of the United States
29 Pharmacopeia;
30 (b) In response to questions from a health care provider or
31 pharmacy, provide access to a pharmacist or nurse employed by the
-5-

AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 specialty pharmacy twenty-four hours per day, seven days per week;
2 (c) Allow a covered person and health care provider to request a
3 refill of a clinician-administered drug on behalf of a covered person in
4 accordance with the pharmacy benefit manager's or health carrier's
5 utilization review procedures; and
6 (d) Adhere to the track and trace requirements, as described in the
7 federal Drug Supply Chain Security Act, 21 U.S.C. 360eee et seq., for a
8 clinician-administered drug that needs to be compounded or manipulated
9 and, if requested by the health care provider or the provider's designee,
10 provide the track and trace information to the health care provider or
11 designee.
12 (2) For any clinician-administered drug dispensed by a specialty
13 pharmacy selected by the pharmacy benefit manager or health carrier, the
14 requesting health care provider or the provider's designee shall provide
15 the requested date, approximate time, and place of delivery of a
16 clinician-administered drug at least five business days before the date
17 of delivery. The specialty pharmacy shall require a signature of the
18 health care provider or the provider's designee upon receipt of the
19 shipment when shipped to a health care provider. If any clinician-
20 administered drug dispensed by a specialty pharmacy is not delivered as
21 specified in this subsection, the covered person shall not be financially
22 responsible if the clinician-administered drug is not able to be
23 administered to the covered person.
24 (3) The requirements of subsections (1) and (2) of this section do
25 not apply when the specialty pharmacy and the health care provider
26 administering the clinician-administered drug have shared ownership.
27 (4) A pharmacy benefit manager or health carrier that requires
28 dispensing of a clinician-administered drug through a specialty pharmacy
29 shall establish and disclose a process which allows the health care
30 provider or pharmacy to appeal and have exceptions to the use of a
31 specialty pharmacy when:
-6-

AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 (a) A drug is not delivered as specified in subsection (2) of this
2 section; or
3 (b) An attending health care provider reasonably believes a covered
4 person may experience harm without the immediate use of a clinician-
5 administered drug that a health care provider or pharmacy has in stock.
6 (5) A pharmacy benefit manager or health carrier shall not:
7 (a) Require a specialty pharmacy to dispense a covered clinician-
8 administered drug directly to a covered person with the intention that
9 the covered person will transport the clinician-administered drug to a
10 health care provider for administration;
11 (b) Refuse to authorize or reimburse a participating provider for
12 dispensing a covered clinician-administered drug based on costs if the
13 costs of the drug to the health benefit plan are substantially similar as
14 compared to the costs of the drug if provided from a specialty pharmacy
15 selected by the pharmacy benefit manager or health carrier;
16 (c) Refuse to authorize or reimburse a participating provider
17 pursuant to the network agreement for the administration of covered
18 clinician-administered drugs;
19 (d) Penalize or remove from the network a participating provider
20 solely for refusing to administer a covered clinician-administered drug
21 received from a specialty pharmacy selected by the pharmacy benefit
22 manager or health carrier. If a participating provider refuses to source
23 covered clinician-administered drugs from a specialty pharmacy selected
24 by the pharmacy benefit manager or health carrier, the participating
25 provider shall direct the covered person to contact the health carrier
26 for coverage options; or
27 (e) Require a covered person to obtain a clinician-administered drug
28 from a specialty pharmacy selected by the pharmacy benefit manager or
29 health carrier if a participating provider of the covered person's choice
30 sources the drug at a substantially similar cost and provides for
31 administration at a substantially similar cost.
-7-

AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 Sec. 5. (1) A health benefit plan, health carrier, or pharmacy
2 benefit manager shall not:
3 (a) Require a covered person, as a condition of payment or
4 reimbursement, to obtain pharmacist services exclusively through the
5 mail-order pharmacy or pharmacy benefit manager affiliate;
6 (b) Prohibit or limit a covered person from selecting a network
7 pharmacist or network pharmacy of the covered person's choice;
8 (c) Transfer a covered person's prescriptions from a network
9 pharmacy to another pharmacy unless requested by the covered person;
10 (d) Use financial incentives, including, but not limited to,
11 adjustments in cost-sharing obligations of a covered person, to the
12 exclusive benefit of the pharmacy benefit manager affiliate pharmacy; or
13 (e) Except as provided in subdivision (2)(b) of this section, auto-
14 enroll a covered person in mail-order pharmacist services.
15 (2) Nothing in this section shall be construed to prevent a health
16 benefit plan, health carrier, or pharmacy benefit manager from:
17 (a) Requiring a covered person to use a network specialty pharmacy;
18 (b) Auto-enrolling a covered person in mail-order pharmacist
19 services for a maintenance medication, provided that a covered person:
20 (i) Shall not be auto-enrolled for the first ninety days of a new
21 maintenance medication; and
22 (ii) Shall have the ability to opt out of mail-order pharmacist
23 services at any time;
24 (c) Informing a covered person of an ability to obtain pharmacist
25 services at a lower cost; or
26 (d) Requiring a covered person to obtain pharmacist services from a
27 mail-order pharmacy or pharmacy benefit manager affiliate when such
28 services are not otherwise available from another network pharmacy.
29 Sec. 6. (1) A network pharmacy or network pharmacist may decline to
30 provide a drug if the pharmacy or pharmacist will be or is paid less than
31 the acquisition cost for the drug.
-8-

AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 (2) If a network pharmacy or network pharmacist declines to provide
2 a drug as authorized in subsection (1) of this section, the pharmacy or
3 pharmacist shall provide the covered person with adequate information as
4 to where the prescription for the drug may be filled or shall refer the
5 covered person to his or her plan sponsor.
6 (3) A pharmacy benefit manager, pharmacy services administrative
7 organization, or any person acting on behalf of a pharmacy benefit
8 manager or pharmacy services administrative organization shall not
9 penalize, remove from the network, or otherwise retaliate against a
10 network pharmacy or network pharmacist solely for declining to provide a
11 drug as provided in subsection (1) of this section.
12 Sec. 7. (1) A contract between a retail pharmacy and a pharmacy
13 benefit manager or plan sponsor shall not prohibit the retail pharmacy
14 from offering the following as an ancillary service of the retail
15 pharmacy:
16 (a) The delivery of a prescription drug by mail or common carrier to
17 a covered person or his or her personal representative on request of the
18 covered person or personal representative if the request is made before
19 the drug is delivered; or
20 (b) The delivery of a prescription to a covered person or his or her
21 personal representative by an employee or contractor of the retail
22 pharmacy.
23 (2) Nothing in this section shall require a retail pharmacy to
24 receive a request from a covered person or his or her personal
25 representative for delivery of a drug by mail, common carrier, or an
26 employee or contractor of the retail pharmacy when refilling or renewing
27 prescription drug services for which a request was previously received,
28 so long as the retail pharmacy has confirmed that the covered person
29 wishes to receive the drug.
30 (3) A pharmacy benefit manager or plan sponsor shall not remove a
31 retail pharmacy from its networks or require a retail pharmacy to join a
-9-

AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 mail-order pharmacy network for the sole reason of providing ancillary
2 delivery services as long as the ancillary delivery services were
3 provided in compliance with this section and with the terms and
4 conditions of the retail pharmacy's contract with the pharmacy benefit
5 manager or plan sponsor and its pharmacy services administrative
6 organization, if applicable.
7 (4) Except as otherwise provided in a contract described in
8 subsection (1) of this section, a retail pharmacy shall not charge a plan
9 sponsor or pharmacy benefit manager for the delivery service described in
10 subsection (1) of this section.
11 (5) If a retail pharmacy provides a delivery service described in
12 subsection (1) of this section to a covered person, the retail pharmacy
13 shall disclose both of the following to the covered person or his or her
14 personal representative:
15 (a) Any fee charged to the covered person for the delivery of a
16 prescription drug; and
17 (b) That the plan sponsor or pharmacy benefit manager may not
18 reimburse the covered person for the fee described in subdivision (a) of
19 this subsection.
20 (6) For purposes of this section, retail pharmacy means a pharmacy
21 that dispenses prescription drugs to the public at retail primarily to
22 individuals who reside in close proximity or who are receiving care from
23 a provider in close proximity to the pharmacy, typically by face-to-face
24 interaction with the individual or the individual's caregiver.
25 Sec. 8. (1) A contract between a pharmacy benefit manager and a
26 health benefit plan that is issued on or after January 1, 2026, shall not
27 contain spread pricing unless such contract is an extension of a contract
28 entered into prior to January 1, 2026, which included spread pricing.
29 (2) Beginning January 1, 2029, no contract between a pharmacy
30 benefit manager and a health benefit plan shall include spread pricing.
31 Sec. 9. This act becomes operative on January 1, 2026.
-10-

AM1201 AM1201
LB198 LB198
MLU - 04/28/2025 MLU - 04/28/2025
1 Sec. 10. Original sections 44-4601, 44-4603, and 44-4610, Revised
2 Statutes Cumulative Supplement, 2024, are repealed.
-11-

[DELETED: yB1 S t o s a i t f nsS24saS 2 S 4 R S C S2041R2(3t r a p b m i c a a f4c w a c b t p b m a 5p6( C p s m a a s7p8r9(0(1s2( C d m a o p3d4(5w t d i p o b a i a t c6p7(1A8L5M]
[DELETED: ( B a h c p a t a t di(o( ( C p m a m p seh((0p1o s e b p t t e n p b2f3o4(5( M m m a d p f a c6l7( N p m a p t h a c8e d o t a p s a9o0a1(2d3a p b m t p c d a a n4r5(6o7w8i9(0a1(1A8L5M]
[DELETED: (f( N o e i a c a w p(((( P p h t s m a i s40(1(2c3(4(5o6o7o8a9(0(1(2(3p4( A h c t t e t i p a c5p s o o p d o d s6e7( P b m a m a p o8p t d o i t o o m9i0c1( P s a o m a e1A8L5M]
[DELETED: t p a c p w c as(( S p m a p t s idi p d t h s s o dr(c p f a d t a p b m c 0h1d o i p t p o p f p2s3S 3 S 4 R S C S42546p7p8(9n0(1o t p b m a w t p b2m3(4(5t a s t t t a c r f a6s7( A t a c t s p t a8i9A0(1t q u r n f t p b1A8L5M]
[DELETED: mo(cu( N f a p b m t m ro(p a ( t a p b m i c0o1r2( N f p o p i o r3a4(5i a o f w t s p6h7(8s a p b m m i c t a9c t a r n t d t t0s1(2c3( P a p c w i s t4a5S 4  ( A s p t s a c6a7(8i9P0( I r t q f a h c p o1p p a t a p o n e b t1A8L5M]
[DELETED: s( A a c p a h c p t r ra w t p b m o h cu(fc d t n t b c o ma0p1d2( F a c d d b a s3p4r5t r d a t a p o d o 6c7o d T s p s r a s o t8h c p o t p d u r o t9s w s t a h c p I a c0a1s2r i t c d i n a t b3a4(5n a w t s p a t h c p6a7( A p b m o h c t r8d9s e a d a p w a t h c0p o p t a a h e t t u o 1s1A8L5M]
[DELETED: (s(p m e h w t i u o a ca(( R a s p t d a c cat c p w t t c d t 0h1( R t a o r a p p f2d a c c d b o c i t3c4c5s6( R t a o r a p p7p t t n a f t a o c8c9( P o r f t n a p p0s1r f a s p s b t p b2m3c4b t p b m o h c t p5p6f7(8f a s p s b t p b m o9h0s t d a a s s c a p f1a1A8L5M]
[DELETED: S 5  ( A h b p h c o pb( R a c p a a c o p or t o p s e t tm( P o l a c p f s a np( T a c p p f a np0( U f i i b n l t1a i c o o a c p t t2e3(4e5(6b7(8( A a c p i m p9s0(1m2( S h t a t o o o m p3s4( I a c p o a a t o p5s6(7m p o p b m a w s8s9S0p1t1A8L5M]
[DELETED: (aptc( A p b m p s ao o a p a o b o a p bm o p s a o s np r f t n o o r a 0n1d2S 7  ( A c b a r p a a p3b4f o t f a a a s o t r5p6(7a8c9t0(1p r b a e o c o t r2p3( N i t s s r a r p t4r a r f a c p o h o h p5r f d o a d b m c c o a6e7p8s l a t r p h c t t c p9w0(1r1A8L5M]
[DELETED: m p n f t s r o p ad s a l a t a d s wp i c w t s a w t t ac o t r p c w t p bm o p s a i p s ao( E a o p i a c d iss0s1( I a r p p a d s d i2s3s4p5( A f c t t c p f t d o 6p7( T t p s o p b m m n8r9t0(1t2i3a4i5S 8  ( A c b a p b m a 6h7c8e9( B J 1 2 n c b a p0b1S1A8L5M]
[DELETED: SS1A8L5M]